Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation

YE Zhenfa; YE Qirao; LAI Xinwei

doi:10.7619/jcmp.201909016

Journal of Clinical Medicine in Practice > 2019 > 23(9): 55-58. > DOI: 10.7619/jcmp.201909016

YE Zhenfa, YE Qirao, LAI Xinwei. Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 55-58. DOI: 10.7619/jcmp.201909016

Citation:

PDF (563 KB)

Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation

First Department of Internal Medicine, Shangyou County People′s Hospital, Shangyou, Jiangxi, 341200

More Information

Received Date: December 24, 2018
Accepted Date: February 19, 2019
Available Online: December 21, 2020
Published Date: May 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To study the effect of warfarin anticoagulation therapy in different intensity on prognosis and long-term efficacy in elderly patients with non-valvular atrial fibrillation.
Methods A total of 90 elderly patients with non-valvular atrial fibrillation admitted to our hospital were divided into low intensity group, standard intensity group and aspirin treatment group according to the intensity of warfarin anticoagulation therapy, with 30 cases in each group. International standardized ratio(INR) of low intensity group was 1.6~2.0, and 2.1~3.0 in standard intensity group. After 3, 6, 12, and 24 months of treatment, the improvement of renal function and the occurrence of thromboembolism, hemorrhage, and endpoint events were compared between the three groups.
Results There was no significant difference in creatinine clearance (Ccr) among the three groups after 3 months of treatment compared with before treatment (P>0.05). Ccr levels of of the three groups were improved after 3-month treatment(P < 0.05). After 6, 12 and 24 months of treatment, the Ccr levels of the low intensity group and the standard intensity group were significantly higher(P < 0.05), and was decreased in aspirin group compared with treatment before(P < 0.05), and significant differences were observed in low intensity group, and standard intensity group(P < 0.05). After treatment, the incidence of thromboembolism of the low intensity group and standard intensity group was significantly lower than that of aspirin group (P < 0.05). The incidence of endpoint events in low intensity group was significantly lower than that in aspirin group (P < 0.05), while there was no significant difference between standard intensity group and aspirin group (P>0.05).
Conclusion Low-intensity warfarin anticoagulation therapy can significantly improve renal function, reduce the incidence of bleeding and improve the safety of medication in the treatment of elderly patients with non-valvular atrial fibrillation.
- warfarin,
- elderly non-valvular atrial fibrillation,
- safety,
- prognosis

FullText(HTML)

References (21)

References

[1]	杨健, 王涛, 庞占琪, 等. 不间断使用达比加群在房颤患者经导管射频消融术围术期抗凝治疗中的安全性及有效性研究[J]. 中国实用医药, 2019, 14(5): 119-120. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA201905065.htm
[2]	张晓丽, 修坤娜, 张晓玲, 等. 非瓣膜性房颤患者口服华法林和新型口服抗凝药物的依从性分析[J]. 中西医结合心血管病杂志, 2019, 7(4): 48-49. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXJH201904030.htm
[3]	Zepeski A, Rewitzer S, Leira E C, et al. Interhospital transfer delays anticoagulation reversal in warfarin-associated intracranial hemorrhage[J]. J Stroke Cerebrovasc Dis, 2018, 27(11): 3345-3349. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.045
[4]	侯晓林, 曾庆华, 陈旸, 等. 利伐沙班与华法林用于房颤导管消融术后疗效及安全性的系统分析[J]. 中国临床药理学杂志, 2019, 35(1): 83-86. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201901024.htm
[5]	张敏, 朱舜明. 非瓣膜性房颤患者华法林抗凝治疗效果的影响因素Logistic回归分析[J]. 临床医学研究与实践, 2019, 4(1): 105-106. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS201901050.htm
[6]	周芃, 陈丰毅, 孙运. 达比加群酯胶囊和华法林钠片对老年持续性房颤患者血清Ⅰ型胶原代谢标志物的影响比较[J]. 中国医学工程, 2018, 26(11): 68-70. https://www.cnki.com.cn/Article/CJFDTOTAL-YCGC201811018.htm
[7]	王微, 杨帆, 田志鹏, 等. 达比加群酯和华法林用于持续房颤患者抗凝治疗的疗效及安全性差异[J]. 中国循证心血管医学杂志, 2018, 10(11): 1385-1388, 1392. doi: 10.3969/j.issn.1674-4055.2018.11.27
[8]	刘学路, 孟永. 口服阿司匹林和华法林对老年稳定性心绞痛伴房颤的影响[J]. 中国老年学杂志, 2018, 38(18): 4366-4367. doi: 10.3969/j.issn.1005-9202.2018.18.006
[9]	Abohelaika S, Wynne H, Avery P, et al. Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery[J]. Thromb Res, 2018, 171: 167-170. doi: 10.1016/j.thromres.2018.09.064
[10]	潘忙忙, 刘晓琰, 顾智淳, 等. 慢性肾功能不全合并非瓣膜房颤患者抗血栓药物治疗的有效性和安全性概述[J]. 药物流行病学杂志, 2018, 27(9): 626-630. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLX201809012.htm
[11]	钱炜春, 王向明, 许健, 等. 导管射频消融术对老年持续性心房颤动的疗效及围手术期抗凝药物安全性分析[J]. 实用老年医学, 2018, 32(7): 643-645. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLA201807013.htm
[12]	熊建华. 低强度华法林抗凝治疗高卒中风险、高出血风险房颤患者的抗栓疗效研究[J]. 当代医学, 2018, 24(18): 153-155. doi: 10.3969/j.issn.1009-4393.2018.18.070
[13]	李晓枫, 张浩, 刘俊, 等. 非瓣膜性心房颤动导管消融围手术期应用利伐沙班的有效性及安全性观察[J]. 中国心脏起搏与心电生理杂志, 2018, 32(3): 237-240. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201803010.htm
[14]	赵婷奕. 华法林治疗非瓣膜病性房颤合并脑梗死的临床疗效及安全性分析[J]. 基层医学论坛, 2018, 22(16): 2190-2191. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLT201816019.htm
[15]	鲁秀秀. 新型抗凝药达比加群与华法林用于老年非瓣膜性房颤患者抗凝治疗的有效性与安全性比较[D]. 济南: 山东大学, 2018.
[16]	Patino M I, Kraus P, Bishop M A. Implementation of patient education software in an anticoagulation clinic to decrease visit times for new patient appointments[J]. Patient Education and Counseling, 2018, 10(22): 1025-1030. http://www.sciencedirect.com/science/article/pii/s0738399118310255
[17]	郝双, 隋国华, 赵庆春, 等. 两种药物用于非瓣膜性房颤伴轻中度肾功能不全患者卒中防治的评价分析[J]. 临床医药文献电子杂志, 2018, 5(38): 14-15. doi: 10.3877/j.issn.2095-8242.2018.38.009
[18]	王军, 张松林, 何璐, 等. 左心耳封堵术与华法林对非瓣膜性房颤病人卒中预防的有效性及安全性对照研究[J]. 中西医结合心脑血管病杂志, 2018, 16(6): 738-741. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201806017.htm
[19]	胥良. 比较达比加群酯和华法林用于房颤患者导管消融围手术期的临床效果[J]. 北方药学, 2018, 15(4): 94-95. doi: 10.3969/j.issn.1672-8351.2018.04.076
[20]	赵燕. 新疆汉族、维吾尔族房颤人群载脂蛋白E基因多态性与华法林剂量的研究[D]. 乌鲁木齐: 新疆医科大学, 2018.
[21]	哈斯高娃, 曹中朝, 刘东华, 等. 利伐沙班与华法林对高龄非瓣膜性房颤患者D-二聚体、NT-proBNP水平的影响[J]. 现代生物医学进展, 2017, 17(32): 6291-6294, 6349. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201732019.htm

[1]	PU Meizhi, FENG Xiaoke, XIE Liqun. Mechanism of Xiaochaihutang in treating gastroesophageal reflux disease with insomnia based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2023, 27(9): 111-118. DOI: 10.7619/jcmp.20230405
[2]	CAI Chuanyun, JIANG Wei, HU Xin. Research progress in treatment of chronic insomnia in the elderly[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 140-143,148. DOI: 10.7619/jcmp.20222374
[3]	LI Jia, WANG Lin, LIU Nan, WANG Ting, ZHAO Xiaoya, GAO Lini, ZHAO Ping. Effect of mindfulness training on sleep quality and psychological state of perimenopausal patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 85-88. DOI: 10.7619/jcmp.20222790
[4]	SHI Yan, WANG Yuanyuan, LIU Xuedong, BAI Ya, MA Lei, LI Wen. Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 49-52. DOI: 10.7619/jcmp.20214395
[5]	ZHANG Lei, LIU Yanwei, BAO Qingxia, FENG Guoqin. Effect of auricular acupoint seed-embedding combined with Limian Plaster on long-term improvement of insomnia in patients with advanced cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 64-66. DOI: 10.7619/jcmp.20210024
[6]	XUAN Jianzong, FENG Xingwen, WU Liangliang, LIU Yuan. Effect observation of Guipi Decoction combined with auricular pressing with pills in treatment of hemodialysis patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 59-62. DOI: 10.7619/jcmp.20210328
[7]	ZHU Jinya, LI Yuhua. Effect of exercise therapy in treatment of patients with chronic schizophrenia accompanied by insomnia[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 57-60. DOI: 10.7619/jcmp.202024017
[8]	CAO Yin, GAO Yanfei, ZHANG Qiaoyang, ZHANG Yi. Effect of cognitive behavioral therapy for insomnia in esophageal cancer patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 22-24,28. DOI: 10.7619/jcmp.201910007
[9]	HU Wenzhe, ZHANG Bo. Effect of psychological intervention for insomnia patients with traumatic brain injury in rehabilitation period[J]. Journal of Clinical Medicine in Practice, 2018, (8): 1-3. DOI: 10.7619/jcmp.201808001
[10]	GAO Lini. Effect of nursing intervention on quality of sleep and quality of life in perimenopausal women with insomnia[J]. Journal of Clinical Medicine in Practice, 2015, (18): 78-80. DOI: 10.7619/jcmp.201518025

Cited By

Cited by

Periodical cited type(5)

1.	洪玫，段宏宪，杨敏. 清肝化湿活血汤联合复方甘草酸苷片治疗酒精性肝病的临床疗效及对患者肝功能的影响. 医药论坛杂志. 2023(02): 87-89+93 .
2.	王箭焱. 舒肝宁注射液联合复方甘草酸苷对非酒精性脂肪性肝炎患者脂代谢、肝功能的影响. 中国医学创新. 2023(22): 45-48 .
3.	陈凯，孟祥林. 多烯磷脂酰胆碱注射液对自身免疫性肝炎患者肝功能指标的影响. 中国药物与临床. 2023(10): 665-669 .
4.	罗萍，蒋玲，刘杨武. 甘草酸制剂治疗病毒性肝炎的效果观察. 继续医学教育. 2022(04): 145-148 .
5.	李斌，王磊. 舒肝消癖颗粒联合复方甘草酸苷片治疗非酒精性脂肪肝的临床效果及对肝功能的影响. 反射疗法与康复医学. 2022(07): 8-10 .

Other cited types(1)

Get Citation

PDF

XML

Article views (353) PDF downloads (4) Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation

Abstract

References

Related Articles

Cited by

Periodical cited type(5)

Other cited types(1)

Catalog

Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation

Abstract

References

Related Articles

Cited by

Periodical cited type(5)

Other cited types(1)

Catalog

Export File

Citation

Format

Content